About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

To Evaluate Safety and Effectiveness of RovatitanTab.

NCT04398771·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

songyi Park
CONTACT
=82-2-6987-4195 songyi-park@lgchem.com

Lead

LG Chem

* Effectiveness: the ratio of patients who reach target BP or LDL-cholesterol * Safety: we will collect safety data

Age

19–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients who have hypertension and hyperlipidemia and older than 19 years
Patients who undertstand purpose and method of study, agree with study

You may not be if

Patients who have been administered Rosuvastatin/Valsartan as a anti- hyperlipiddemic/anti-hypertensive drugs
Uncontrolled hypertension (SBP\>=180mmHg or DBP\>=110mmHg)
Patients who participated another clinical study or observational study 3 months ago.

The record

StatusUnknown

PhaseNo phase

Taking part1,000

StartedSep 2020

UpdatedMay 21, 2020

Conditions

Hypertension Hyperlipidemias

Clareo Health | To Evaluate Safety and Effectiveness of RovatitanTab.